Related Experiment Video
Updated: Sep 11, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Temporary Mechanical Circulatory Support for Acute Myocardial Infarction Cardiogenic Shock
Saliha Erdem1, Dhruvil Ashishkumar Patel2, Karl Abou Zeid3
1Houston Methodist, Houston, Texas, US.
Insights
Temporary mechanical circulatory support (tMCS) devices offer improved outcomes for patients experiencing cardiogenic shock (CS) after acute myocardial infarction (AMI). This review evaluates tMCS evidence and guidelines to aid clinical decision-making.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) presents significant challenges with high mortality rates.
- Temporary mechanical circulatory support (tMCS) is increasingly favored for hemodynamic stabilization and improved survival in AMI-CS.
Purpose of the Study:
- To review the pathophysiology of AMI-CS.
- To examine evidence and guidelines for implementing tMCS devices in AMI-CS.
- To assist clinicians in decision-making regarding tMCS use.
Main Methods:
- Literature review focusing on clinical trial data and recent guideline recommendations.
- Examination of the pathophysiology of AMI-CS.
- Evaluation of various tMCS devices including intra-aortic balloon pump, Impella, TandemHeart, and venoarterial extracorporeal membrane oxygenation.
Main Results:
- tMCS devices can effectively stabilize hemodynamics and improve cardiac output in patients with AMI-CS.
- Evidence from clinical trials and guidelines supports the use of tMCS for selected patients.
- Specific tMCS devices show varying degrees of efficacy and operator preference.
Conclusions:
- tMCS plays a crucial role in managing cardiogenic shock complicating acute myocardial infarction.
- Understanding the evidence base and guideline recommendations is essential for optimal tMCS implementation.
- Further research may refine device selection and patient management strategies in AMI-CS.
Abstract:
Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) remains a critical clinical challenge associated with high morbidity and mortality. Temporary mechanical circulatory support (tMCS) devices can stabilize hemodynamics, improve cardiac output, and enhance survival, thereby continuing to be more favorable with operators. This review summarizes the pathophysiology of AMI-CS and examines the evidence informing recommendations for tMCS device implementation-specifically the intra-aortic balloon pump, Impella (Abiomed/J&J MedTech), TandemHeart™ (LivaNova, Inc.), and venoarterial extracorporeal membrane oxygenation-with a particular focus on clinical trial data and recent guideline recommendations to assist operators in implementing decision-making.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome I: Introduction

